RNS Number : 2014Z
Ubisense Group PLC
30 August 2018
 

30 August 2018

 

Ubisense Group plc

Board Update

Ubisense Group plc ('Ubisense'), announces that Peter Harverson, Non-Executive Chairman, is taking a temporary leave of absence in order to receive medical treatment.

During Peter's absence Paul Taylor, Non-Executive Director, has agreed to become Acting Non-Executive Chairman of Ubisense effective from today. No further changes to the operation of the Board are anticipated as a result.

The Board wishes Peter a quick and full recovery, and looks forward to welcoming him back to the business in due course.

For further information contact:

 

Ubisense Group plc                                                                         +44 (0) 1223 535170

Richard Petti

Tim Gingell

 

finnCap Ltd                                                                                       +44 (0) 20 7220 0500

Henrik Persson, Anthony Adams (Corporate Finance)

Tim Redfern, Richard Chambers (Corporate Broking)

 

Tulchan Communications LLP                                                        +44 (0) 20 7353 4200

James Macey White, Matt Low, Deborah Roney

 

 

About Ubisense

 

Ubisense (AIM: UBI), a global leader in Enterprise Location Intelligence solutions, is a trusted adviser to some of the biggest automotive, aerospace, communications and utility companies in the world. Our solutions are based on powerful enterprise platforms, supported by a range of customer-led applications, that use location to deliver a real-time digital twin of our customer's physical operations, proven to drive quality, increase productivity, manage complexity and reduce costs.

 

Founded in 2002, Ubisense is headquartered in Cambridge, UK and has subsidiary companies in France, Germany, USA, Canada and Japan. For more information visit: www.ubisense.net.

 

 

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
UPDKKLFLVVFFBBQ